Study #2016-0549
Organ Preservation with AcTive SurveIllance after NeOadjuvant Therapy in Rectal CaNcer (OPTION)
MD Anderson Study Status
Enrolling
Treatment Agent
Chemotherapy
Description
This pilot trial studies how well active surveillance and chemotherapy before surgery work in treating participants with stage II-III rectal cancer. Active surveillance involves monitoring participants for additional tumor growth after receiving cancer treatment. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether deferring surgery after active surveillance and chemotherapy will work better in treating participants with stage II-III rectal cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC V8, Stage IIA Rectal Cancer AJCC V8, Stage IIB Rectal Cancer AJCC V8, Stage IIC Rectal Cancer AJCC V8, Stage III Rectal Cancer AJCC V8, Stage IIIA Rectal Cancer AJCC V8, Stage IIIB Rectal Cancer AJCC V8, Stage IIIC Rectal Cancer AJCC V8
Study phase:
Phase I (Early)
Physician name:
George Chang
Department:
Colon and Rectal Surgery
For general questions about clinical trials:
1-855-404-4637
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.